Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Emerging Therapies Drive Analytical Advancements

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Analyzing Exabytes

Effective analytics will eliminate failures, deviations, and non-conformances.

Week of Sept. 7, 2009: Facet Rejects Biogen Idec's Proposal; Roche Announces Management Changes; More...

September 10, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma appoints CEO and chairman; more...

Week of Aug. 31, 2009: Roche Purchases Lonza Facility; SCOLR Pharma Names CEO; More...

September 03, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...

Pharma Capsules

September 02, 2009

Brief pharmaceutical news items for September 2009.

Quality by Enforcement

September 02, 2009

After years of promomting QbD concepts, FDA's ready to take action on nonconformers.

The Go/No-Go Mindset

September 02, 2009

As new process validation guidelines emerge, industry needs to reinvent how it releases product.

Inside IPEC–Americas: Evaluating Excipient Stability

September 02, 2009

IPEC's new stability testing guide takes into account the full supply chain's storage conditions.

Pharmaceutical Technology Europe

The benefits of risk-based analyses during system validation

September 01, 2009

When validating automated systems from third-party providers, using the V model and failure modes effects and criticality analysis (FMECA) early in the process can help.

Week of Aug. 24, 2009: Warner Chilcott Buys P&G Pharma Business; Amylin Appoints Former Novartis Exec As Chairman; More...

August 27, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: UCB and Novartis form agreement; AAIPharma appoints VP of regulatory affairs; more...

Company and People Notes: Forest Labs and AstraZeneca Form Pact; Endo COO Resigns; More...

August 20, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Also, XCELERON and GSK form agreement; Millipore appoints VP of life sciences; more...

Company and People Notes: Nabi and GSK Form Pact; Cardinal Health Names CEO; More...

August 13, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Also: DSM's North Carolina facility receives SafeBridge certification; Dynavax CFO to retire; more...